Cargando…
Identification of new Wilms tumour predisposition genes: an exome sequencing study
BACKGROUND: Wilms tumour is the most common childhood renal cancer and is genetically heterogeneous. While several Wilms tumour predisposition genes have been identified, there is strong evidence that further predisposition genes are likely to exist. Our study aim was to identify new predisposition...
Autores principales: | Mahamdallie, Shazia, Yost, Shawn, Poyastro-Pearson, Emma, Holt, Esty, Zachariou, Anna, Seal, Sheila, Elliott, Anna, Clarke, Matthew, Warren-Perry, Margaret, Hanks, Sandra, Anderson, John, Bomken, Simon, Cole, Trevor, Farah, Roula, Furtwaengler, Rhoikos, Glaser, Adam, Grundy, Richard, Hayden, James, Lowis, Steve, Millot, Frédéric, Nicholson, James, Ronghe, Milind, Skeen, Jane, Williams, Denise, Yeomanson, Daniel, Ruark, Elise, Rahman, Nazneen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472290/ https://www.ncbi.nlm.nih.gov/pubmed/30885698 http://dx.doi.org/10.1016/S2352-4642(19)30018-5 |
Ejemplares similares
-
The ICR639 CPG NGS validation series: A resource to assess analytical sensitivity of cancer predisposition gene testing
por: Mahamdallie, Shazia, et al.
Publicado: (2018) -
The Quality Sequencing Minimum (QSM): providing comprehensive, consistent, transparent next generation sequencing data quality assurance
por: Mahamdallie, Shazia, et al.
Publicado: (2018) -
CoverView: a sequence quality evaluation tool for next generation sequencing data
por: Münz, Márton, et al.
Publicado: (2018) -
Germline mutations in the PAF1 complex gene CTR9 predispose to Wilms tumour
por: Hanks, Sandra, et al.
Publicado: (2014) -
ICR142 Benchmarker: evaluating, optimising and benchmarking variant calling performance using the ICR142 NGS validation series
por: Ruark, Elise, et al.
Publicado: (2018)